FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.090
+0.040 (3.81%)
At close: May 18, 2026, 4:00 PM EDT
1.067
-0.023 (-2.07%)
After-hours: May 18, 2026, 7:30 PM EDT
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,245,333
Market Cap
5.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| TransCode Therapeutics | 12 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| MetaVia | 8 |
| Silo Pharma | 3 |
| Alaunos Therapeutics | 1 |
FBLG News
- 16 hours ago - FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics - GlobeNewsWire
- 7 days ago - FibroBiologics expands fibroblast-based platform to target Hantavirus - TheFly
- 7 days ago - FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus - GlobeNewsWire
- 13 days ago - FibroBiologics CEO Issues Letter to Shareholders - GlobeNewsWire
- 14 days ago - FibroBiologics says fibroblast spheroids drive burn healing, reduce scarring - TheFly
- 14 days ago - FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring - GlobeNewsWire
- 14 days ago - FibroBiologics releases first batch of CYWC628 for Phase 1/2 trial - TheFly
- 14 days ago - FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial - GlobeNewsWire